MedTech Industry Dynamics
MedTech Industry Dynamics
NeuroXess has completed a 700 million yuan Series B financing round to support multi-center clinical trials, regulatory approval, construction of a mass-production super factory, and next-generation product development for its fully implanted, fully wireless, fully functional brain-computer interface system.
Read MoreParadromics and Siemens Healthineers have announced a collaboration to develop an advanced multimodal imaging platform designed to support the growing clinical use of implantable brain-computer interfaces, spanning patient assessment, surgical planning, implantation, and long-term outcomes.
Read MoreMintNeuro has raised $5 million to accelerate commercial scale-up of its specialized semiconductor chips for neural devices and brain-computer interfaces, with funding from European and U.S. investors to drive product launch, partner adoption, and international expansion.
Read MoreINBRAIN Neuroelectronics and the European Commission-funded MINIGRAPH consortium have completed a project developing ultra-thin graphene neural interfaces, implantable electronics, and a magnetically guided robotic implantation procedure to advance next-generation autonomous neuroelectronic therapies.
Read MoreBridge Neurotech has emerged from stealth and announced a research and development agreement with Butterfly Network through the Butterfly Embedded program, leveraging Butterfly’s programmable Ultrasound-on-Chip technology to pursue a fully non-invasive brain-computer interface without surgery or implants.
Read MorePrecision Neuroscience has closed an oversubscribed $250 million Series D financing round co-led by Pershing Square, the Ackman Oxman Institute, and an undisclosed life sciences investment fund, bringing total capital raised to $430 million and supporting expansion of its clinical program and Layer 7 cortical interface.
Read MoreNon-invasive AI brain-computer interface company BCI-Sonics has raised 200 million yuan in a Pre-A financing round co-led by Sequoia China and Yunqi Partners, bringing total funding to nearly 300 million yuan to support product development, clinical research, and AI infrastructure.
Read MoreParadromics has received FDA approval to expand the types of computing devices that may be used with its investigational brain-computer interface (BCI) system in the Connect-One clinical study, enabling compatibility with personal laptops, tablets, and phones through its Convey user interface.
Read MoreThe first National MRI-Brain-Computer Interface (BCI) Summit in Tianjin unveiled uMR ShenGuan, the world’s first full-stack MRI-specific solution for BCI research and clinical translation, alongside a new industry alliance co-founded by Tianjin University and United Imaging.
Read MoreNeuvotion is advancing its brain-body interface platform following a landmark Nature Medicine study demonstrating that a “double neural bypass” system can restore both movement and sensation in patients with paralysis, with the company’s first commercial product, NeuStim, launching this fall.
Read More
